Minimal inhibitory concentrations of sulbactam/ampicillin against drug sensitive and drug resistant isolates of Mycobacterium tuberculosis

Microbios

Volumn 89, Issue 360-361, 1997, Pages 135-141

  Paramasivan, C N ^a   Venkataraman, P ^a   Herbert, D ^a  

^a NONE

Author keywords

In vitro antimicrobial testing; Minimal inhibitory concentration; Mycobacterium tuberculosis; Sulbactam ampicillin

Indexed keywords

AMPICILLIN;

ARTICLE; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIUM TUBERCULOSIS; PENICILLIN RESISTANCE;

AMPICILLIN; AMPICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS;

EID: 0030634243     PISSN: 00262633     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. ABRAHAM E. P., Chain E. and Fletcher C. M. 1941. Further observations on penicillin. Lancet 2 177-88.
2. BROWN A. G., Butterworth D., Cole M., Hanscomb G., Hood J. D., Reading C. and Rolinson G. N. 1976. Naturally occurring β-lactamase inhibitors with antibacterial activity. J. Antibiot. 29 668-9.
3. BUSH K. 1988. β-Lactamase inhibitors from laboratory to clinic. Clin. Microbiol. Rev. 1 109-23.
4. CASAL M. J., Rodriguez F. C., Luna M. D. and Benavente M. C. 1987. In vitro susceptibility of M. tuberculosis, M. africanum, M. bow's, M. avium, M. fortuitum and M. chelonei to ticarcillin in combination with clavulanic acid. Antimicrob. Agents Chemother. 31 132-3.
5. ENGLISH A. R., Retsema J. A., Girard A. E., Lynch J. E. and Barth W. E. 1978. CP-45 899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterisation. Antimicrob. Agents Chemother. 14 414-9.
6. FOULDS G. 1986. Pharmacokinetics of sulbactam/ampicillin in humans: a review. Rev. Infect. Dis. 8 (Suppl 5) S503-11.
7. FOULDS G., Stankewich J. P., Marshall D. C., O'Brien M. M., Hayes S. L., Weidler D. J. and McMahon F. G. 1983. Pharmacokinetics of sulbactam in humans. Antimicrob. Agents Chemother. 23 692-9.
8. GOBLE M., Iseman M. D., Madsen L. A., Waite D., Ackerson L. and Horsburgh R. Jr. 1993. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. New Engl. J. Med. 328 527-32.
9. HAND C. N. and Bains S. 1949. The effect of penicillin on the tubercle bacillus. J. Path. Bact. 61 329-35.
10. HERBERT D., Paramasivan C. N., Venkatesan P., Kubendiran G., Prabhakar R. and Mitchison D. A. 1996. Evaluation of bactericidal action of ofloxacin and sulbactam/ampicillin, alone and in combination with rifampicin and isoniazid, on M. tuberculosis in vitro. Antimicrob. Agents Chemother. 40 2296-9.
11. HONG KONG Chest Services/British Medical Research Council. 1992. A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Tuberc. Lung. Dis. 7357-67.
12. KAMALA T., Herbert D., Venkatesan P. and Paramasivan C. N. 1997. Minimal inhibitory concentrations of lomefloxacin and minocycline against drug sensitive and drug resistant isolates of Mycobacterium tuberculosis compared on LJ and 7H11. Int. J. Leprosy In press.
13. KASIK J. E. 1964. Activity of some semisynthetic penicillins on Mycobacterium tuberculosis. In Antimicrobial Agents and Chemotherapy. pp 315-20. American Society of Microbiology, Ann Arbor, Michigan, U.S.A.
14. KASIK J. E., Weber M., Winberg E. and Barclay W. R. 1966. The synergistic effect of dicloxacillin and penicillin G on murine tuberculosis. Am. Rev. Respir. Dis. 94 260-1.
15. KASIK J. E., Weber M. and Freehill P. J. 1967. The effect of the penicillinase resistant penicillins and other chemotherapeutic substances on the penicillinase of the R1Rv strain of Mycobacterium tuberculosis. Am. Rev. Respir. Dis. 95 12-9.
16. LEES L., Milson J. A., Knirsch A. K. and Greenhalgh K. 1986. Sulbactam plus ampicillin: interim review of efficacy and safety for therapeutic and prophylactic use. Rev. Infect. Dis. 8 S644-50.
17. MITCHISON D. A., Ellard G. A. and Grosset J. 1988. New antibacterial drugs for the treatment of mycobacterial disease in man. Br. med. Bull. 44 757-74.
18. NADLER J. P., Berger J., Nord J. A., Cofsky R. and Saxena M. 1991. Amoxicillin-clavulanic acid for treating drug resistant Mycobacterium tuberculosis. Chest 99 1025-6.
19. NAGPAUL D. R. 1994. Multidrug resistance in tuberculosis. Ind. J. Tuberc. 41 1-2.
20. O'BRIEN R. J. and Snider D. E. Jr. 1985. Tuberculosis - old and new. Am. Rev. Respir. Dis. 131 309-11.
21. PARENTI F. 1989. New experimental drugs for the treatment of tuberculosis. Rev. Infect. Dis. 11 (Suppl 2) 5479-83.
22. PRABHAKARAN K., Harris E. B., Randhawa B. and Hastings R. C. 1992. Reversal of drug resistance in Mycobacterium leprae by ampicillin/sulbactam. Microbios 72 137-42.
23. REMA M., Santha T., Parthasarathy R., Rajaram K., Paramasivan C. N., Janardhanam B., Somasundaram P. R. and Prabhakar R. 1993. Response of patients with initially drug resistant organisms to treatment with short course chemotherapy. Ind. J. Tuberc. 40 119-23.
24. RILEY L. W. 1993. Drug resistant tuberculosis. Clin. Infect. Dis. 17 (Suppl 2) S442-4.
25. RIPA S., Ferrante L and Prenna M. 1990. Pharmacokinetics of sulbactam/ampicillin in humans after intravenous and intramuscular injection. Chemother. 36 185-92.
26. RODRIGUEZ W. J., Khan W. N., Ping J., Feris J., Harmon S., Gold B. G. and Ahmad S. 1986. Sulbactam/ampicillin for the treatment of meningitis in infants and children. Rev. Infect. Dis. 8 S620-9.
27. SELVAKUMAR N., Vanajakumar K., Acharyulu G. S., Fathima Rehman, Paramasivan C. N. and Prabhakar R. 1992. Tuberactinomycin susceptibility of M. tuberculosis isolated from South India. Ind. J. Med. Res. 95 101-4.
28. SOLTYS M. A. 1952. The effect of penicillin on mycobacteria in vitro and in vivo. Tubercle 33 120-5.
29. SORG T. B. and Cynamon M. H. 1987. Comparison of four beta lactamase inhibitors in combination with ampicillin against Mycobacterium tuberculosis. J. Antimicrob. Chemother. 19 59-64.
30. VENKATARAMAN P., Paramasivan C. N. and Prabhakar R. 1992a. In vitro activity of rifampicin, rifapentine and rifabutin against South Indian isolates of M. tuberculosis. Ind. J. Tuberc. 40 17-20.
31. VENKATARAMAN P., Paramasivan C. N. and Prabhakar R. 1992b. In vitro activity of capreomycin and ciprofloxacin against South Indian isolates of M. tuberculosis. Ind. J. Tuberc. 40 21-4.
32. VENKATARAMAN P., Paramasivan C. N. and Prabhakar R. 1992c. In vitro activity of ciprofloxacin and ofloxacin against South Indian isolates of M. tuberculosis. Ind. J. Tuberc. 41 87-90.
33. WISE R. 1986. The clinical relevance of protein binding and tissue concentration in antimicrobial therapy. Clin. Pharmacokinetics 11 583-7.